AR243239A1 - Procedimiento para preparar polipeptido. - Google Patents

Procedimiento para preparar polipeptido.

Info

Publication number
AR243239A1
AR243239A1 AR90318636A AR31863690A AR243239A1 AR 243239 A1 AR243239 A1 AR 243239A1 AR 90318636 A AR90318636 A AR 90318636A AR 31863690 A AR31863690 A AR 31863690A AR 243239 A1 AR243239 A1 AR 243239A1
Authority
AR
Argentina
Prior art keywords
polypeptide
preparing
procedure
Prior art date
Application number
AR90318636A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928562A external-priority patent/GB8928562D0/en
Priority claimed from GB909004414A external-priority patent/GB9004414D0/en
Priority claimed from GB909004814A external-priority patent/GB9004814D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of AR243239A1 publication Critical patent/AR243239A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR90318636A 1989-12-18 1990-12-17 Procedimiento para preparar polipeptido. AR243239A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898928562A GB8928562D0 (en) 1989-12-18 1989-12-18 Viral agent
GB909004414A GB9004414D0 (en) 1990-02-27 1990-02-27 Viral agent
GB909004814A GB9004814D0 (en) 1990-03-03 1990-03-03 Viral agent

Publications (1)

Publication Number Publication Date
AR243239A1 true AR243239A1 (es) 1993-07-30

Family

ID=27264852

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90318636A AR243239A1 (es) 1989-12-18 1990-12-17 Procedimiento para preparar polipeptido.

Country Status (24)

Country Link
US (1) US6210675B1 (es)
JP (1) JPH06107687A (es)
AR (1) AR243239A1 (es)
AT (1) AT400724B (es)
AU (1) AU642942B2 (es)
BE (1) BE1005485A5 (es)
BR (1) BR9006422A (es)
CA (1) CA2032381C (es)
CH (1) CH684594A5 (es)
DE (1) DE4040339C2 (es)
DK (1) DK298190A (es)
ES (1) ES2029171A6 (es)
FI (1) FI906208A (es)
FR (1) FR2655990A1 (es)
GB (1) GB2239245B (es)
GR (1) GR1001261B (es)
HU (1) HUT56883A (es)
IE (1) IE65172B1 (es)
IT (1) IT1242183B (es)
LU (1) LU87861A1 (es)
NL (1) NL9002779A (es)
NO (1) NO905438L (es)
NZ (1) NZ236491A (es)
SE (1) SE9004010A (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
RU2130969C1 (ru) * 1990-04-04 1999-05-27 Чирон Корпорейшн Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
AU660925B2 (en) * 1990-04-06 1995-07-13 Genelabs Technologies, Inc. Hepatitis C virus epitopes
JP3549201B2 (ja) * 1990-10-24 2004-08-04 中外製薬株式会社 非ａ非ｂ型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
JPH06508026A (ja) * 1991-05-08 1994-09-14 カイロン　コーポレイション 診断と治療に用いるｈｃｖゲノム配列
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
WO1993002193A1 (es) * 1991-07-19 1993-02-04 Bartolome Nebreda Fernando Jav cDNAS DERIVADOS DEL VIRUS C DE LA HEPATITIS
DK0529493T3 (da) * 1991-08-27 1998-08-24 Hoffmann La Roche Fremgangsmåder og reagenser til hepatitis C-detektion
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
BR9405334A (pt) 1993-04-27 1999-05-25 Innogenetics Nv Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
EP0729973A4 (en) * 1993-10-29 1998-12-30 Srl Inc AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE
DE69526973T3 (de) 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
US6071721A (en) * 1998-11-13 2000-06-06 Incyte Pharmaceuticals, Inc. Calcium binding protein
US7829085B2 (en) 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
US7067313B1 (en) * 1999-07-14 2006-06-27 D. Collen Research Foundation Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
CU23244A1 (es) * 2001-07-16 2007-10-17 Ct Ingenieria Genetica Biotech Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
EP1546414B1 (en) * 2002-09-09 2008-10-08 Novartis Vaccines and Diagnostics, Inc. Hcv assay
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
EP1706079B1 (en) * 2003-08-14 2013-02-20 ThromboGenics N.V. Antibodies against factor viii with modified glycosylation in the variable region
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
EP2833900B1 (en) 2012-04-01 2018-09-19 Technion Research & Development Foundation Limited Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
EP3740224A4 (en) * 2018-01-18 2022-05-04 Adanate, Inc. ANTI-LILRB ANTIBODIES AND THEIR USES

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
GB2108527B (en) 1981-02-11 1984-10-24 Connaught Lab Non-a non-b hepatitis virus
US4542016A (en) 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58183629A (ja) 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4707439A (en) 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
GB8431171D0 (en) 1984-12-11 1985-01-23 Technology Licence Co Ltd Monoclonal antibodies
JPS61176856A (ja) 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非ａ非ｂ型肝炎抗原
US4673634A (en) 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
FR2597606B1 (fr) 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
JPS6391328A (ja) 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎抗原
NZ222465A (en) * 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
DE3744242A1 (de) 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
AU632271B2 (en) 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
WO1989012641A1 (en) 1988-06-17 1989-12-28 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
AU4046489A (en) * 1988-07-06 1990-02-05 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
IL91371A0 (en) 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
AU638719B2 (en) * 1989-05-18 1993-07-08 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
ES2110411T3 (es) 1989-08-25 1998-02-16 Chiron Corp Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
JP3156200B2 (ja) 1989-09-15 2001-04-16 国立予防衛生研究所長 新規のｈｃｖ分離株
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
RU2130969C1 (ru) 1990-04-04 1999-05-27 Чирон Корпорейшн Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide

Also Published As

Publication number Publication date
IT9048588A0 (it) 1990-12-17
HUT56883A (en) 1991-10-28
NL9002779A (nl) 1991-07-16
GR1001261B (el) 1993-06-30
FR2655990B1 (es) 1995-04-07
NZ236491A (en) 1993-10-26
ATA257190A (de) 1995-07-15
SE9004010A (sv) 1991-06-19
GR900100868A (en) 1992-05-12
CH684594A5 (fr) 1994-10-31
NO905438L (no) 1991-06-19
GB2239245B (en) 1993-11-10
AU642942B2 (en) 1993-11-04
FR2655990A1 (fr) 1991-06-21
IT1242183B (it) 1994-02-16
AU6817590A (en) 1991-06-20
NO905438D0 (no) 1990-12-17
US6210675B1 (en) 2001-04-03
GB9027250D0 (en) 1991-02-06
CA2032381C (en) 2006-02-21
JPH06107687A (ja) 1994-04-19
SE9004010D0 (sv) 1990-12-17
DK298190D0 (da) 1990-12-17
BR9006422A (pt) 1991-09-24
FI906208A (fi) 1991-06-19
GB2239245A (en) 1991-06-26
DK298190A (da) 1991-06-19
SE9004010L (es) 1991-06-19
IE904540A1 (en) 1991-06-19
ES2029171A6 (es) 1992-07-16
BE1005485A5 (fr) 1993-08-10
DE4040339C2 (de) 1999-07-08
LU87861A1 (fr) 1991-10-08
FI906208A0 (fi) 1990-12-17
IE65172B1 (en) 1995-10-04
HU908296D0 (en) 1991-06-28
AT400724B (de) 1996-03-25
DE4040339A1 (de) 1991-06-20
IT9048588A1 (it) 1991-06-19
CA2032381A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
AR243239A1 (es) Procedimiento para preparar polipeptido.
SG91694G (en) Process for preparing a soy sauce.
GR3032555T3 (en) Process for preparing a flavouring agent.
GR900100165A (en) Method for preparing sulfo-triazolo-diazepino-derivatives
AR245131A1 (es) Un procedimiento para preparar agentes antiparasitarios.
GR900100541A (en) Machine for preparing ice-cubes
AR242795A1 (es) Un procedimiento para preparar imidazo rifamicina
EP0585216A4 (en) PEPTIDES AGAINST INFECTIOUS MONONUCLEOSIS.
IL88943A0 (en) Process for preparing 1-alkyl-5-nitroimidazoles
GB2216519B (en) Process for preparing n-sulphonyl-ureas
IL95980A0 (en) Process for preparing n,n'-bistetrabromophthalimide)
KR960009690B1 (en) Process for preparing polyarylenethioether
AR243892A1 (es) Procedimiento para obtener dipirido-imidazo-rifamicina.
CS532290A3 (en) Process for preparing 1,1-dichlorotetrafluoroethane
GB2222403B (en) Process for preparing 2-methoxyisobutylisonitrile
EP0593452A4 (en) METHOD FOR PRODUCING A PROTEIN MARKED WITH METAL RADIONUCLIDE.
AR245139A1 (es) Un proceso para la preparacion de peptidos.
YU146589A (en) Process for preparing new alylaminoethyl-azoles
IE891125L (en) Preparing polypeptides
IE881839L (en) Process for preparing 3-amino-2-methylbenzotrifluoride.
AR243152A1 (es) Un procedimiento de obtencion de 1,2-diamino-bencenos 4-sustituidos.
PL276494A1 (en) Method for the tionaphthene preparation
KR0142108B1 (en) Process for preparing 4-demethoxydaunomycinone
GB8907660D0 (en) Polypeptide
IE891355L (en) Preparing ketophosphonates